AKT1 and neoplasm: Dual-luciferase assays verified that miR-485-3p may want to directly bind to Akt3 mRNA, inhibiting the Akt/mTOR pathway in tumor cells, thus inhibiting cellular glycolysis, proliferation, and invasion, and acting as a tumor suppressor.